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or position, with no single imaging modality encompassing all 
potential GTV regions. These data suggest delineation based 
upon multimodality imaging has the potential to improve the 
accuracy of GTV definition, which is important for highly 
volumetric approaches to target volume delineation and dose 
escalation strategies.  
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Purpose/Objective: Conventional MRI for target definition of 
glioblastoma (GB) may receive inadequate radiation dose 
coverage of the nonenhanced (NE) hypercellular (HC) 
subvolume resulting in reduced therapeutic efficacy. It is a 
challenge to differentiate NE solid tumor from edema using 
conventional FLAIR and ADC (b≤1000 s/mm2) images. This 
study aimed to develop a technique to identify the HC 
components of GB by using high b-value diffusion weighted 
imaging (DWI) and to investigate the relationship of these 
components with the enhanced subvolumes, 95% prescribed 
radiation dose volume (95PDV) and progression-free survival 
(PFS). 
Materials and Methods: 21 patients (age: 23-76 years) with 
GB were treated by radiation therapy (RT) after surgical 
resection or biopsy. RT planning was based upon conventional 
MRI. During MRI simulation, DWI was acquired in 3 orthogonal 
directions with b-values of 0, 1000, and 3000 s/mm2. Gross 
tumor volume (GTV-Gd) and FLAIR abnormality volume (FLAIR 
TV) were defined on post-Gadolinium T1-weighted and T2 
FLAIR images pre-RT. High b-value (3000 s/mm2) DWI, in 
which fluid, edema, grey and white matter, to an extent, are 
suppressed, were used to define the HC volume (HCV) by 
using a threshold (mean intensity + 2 SD) calculated from a 
VOI in normal-appearing tissue most contralateral to the 
tumor (Fig 1). All images, including planning CT (dose 
distribution) and MRI at recurrence, were registered to post-
Gd T1WI pre-RT. Relationships between the HCV, GTV-Gd, 
FLAIR TV, 95PDV and PFS were analyzed. 
 
 
 
Results: The HCVs and NE HCVs varied from 0.58 to 67 cc 
(median: 9.8 cc) and 0.15 to 60 cc (median: 2.5 cc), 
respectively. 14 patients had incomplete dose coverage of 
the HCV, of which 6 patients had 1 cc or more HCV missed by 
the 95PDV (range: 1.01-25.4 cc), indicating insufficient 
radiation dose coverage of the HCVs when using conventional 
MRI. In 7 patients, HCVs extended beyond FLAIR TVs an 
average of 13 mm (range: 5-27 mm). However, overall, HCVs 
were only a median 12% of the FLAIR TVs (median volume of 
70 cc and range: 23-180 cc), indicating a potential risk of 
radiation toxicity if FLAIR TV is used to guide high-dose 
treatment. Of the 15 patients who had progression, 5 
patients progressed earlier, within 6 months post-RT, and 10 
patients after. Pre-RT HCVs within the recurrent GTVs-Gd 
were 78% (range: 65-89%) for the earlier progression subgroup 
and 53% (range: 0-85%) for the later progression subgroup, 
indicating the consequence of HCV on PFS. In fact, HCV and 
NE HCV were significant negative prognostic indicators for 
PFS (univariate cox regression, n = 21, p < 0.002 and p < 0.01, 
respectively). The volume of HCV that was not covered by 
the 95PDV was also a significant negative predictor for PFS (p 
< 0.05), substantiating the importance of high dose coverage 
of the HCV.  
Conclusions: High b-value DWI identifies the HC components 
of GB and could aid in RT target volume definition. Future 
pathological studies will allow us to investigate the role of 
high b-value DWI in identifying radiation boost volumes and 
diagnosing progression. 
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Purpose/Objective: Hyperthermia treatment (HT) aims at 
tumour heating to approximately 43°C using RF antennas for 
energy deposition. For accurate Hyperthermia Treatment 
Planning (HTP), the knowledge of patient-specific electrical 
tissue conductivity (σ) values is required. Currently, HTP 
applies literature values for σ, which show large variations 
due to variable measuring conditions (e.g. in vivo, ex vivo, 
temperature) and use of various species. As σ has a strong 
impact on the Specific Absorption Rate (SAR) and 
temperature distribution, studies have shown that 
uncertainties in tissue σ can lead to inaccuracies of 20% in 
both SAR and temperature predictions for HTP. Therefore, 
accurate σ values are essential for reliable patient-specific 
HTP. Moreover, tumor σ is unknown; therefore currently σ 
values of muscle are applied. Our aim is to acquire patient-
specific tissue σ non-invasively using MRI. 
Materials and Methods: In vivo σ reconstructions were 
performed using the Electric Property Tomography (EPT) 
method which reconstructs the tissue σ from the B1+ fields, as 
measurable by standard MRI systems. We have validated this 
method earlier using phantom experiments and in vivo 
simulations in the pelvic region. In the present study, in vivo 
3T MRI measurements of 12 cervical (squamous cell) 
carcinoma patients and one uterine adenocarcinoma patient 
were used to reconstruct σ values in tumor, muscle and 
bladder. For a reliable σ reconstruction using EPT, the size of 
a particular tissue type should be relatively homogenous and 
large enough (>3cm), therefore, the σ of 9 tumors and 7 
bladder fillings could be reliably reconstructed. Results were 
compared to literature data. 
